Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1125 of 2228 entries
View as:

BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I

Phase: N/A Priority: Normal
NCT ID: NCT00876460 Org: User:
Start: 03/31/09 End: 07/31/15 Due: 07/31/16

Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)

Phase: N/A Priority: Normal
NCT ID: NCT02839746 Org: User:
Start: 06/13/16 End: 10/10/18 Due: 10/10/19

Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI)

Phase: N/A Priority: Normal
NCT ID: NCT02184234 Org: User:
Start: 06/30/01 End: - Due: -

Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial Design

Phase: N/A Priority: Normal
NCT ID: NCT00798161 Org: User:
Start: 12/31/08 End: - Due: -

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT06745297 Org: User:
Start: 01/23/25 End: 12/23/25 Due: 12/23/26

Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259777 Org: User:
Start: 09/30/07 End: - Due: -

Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity

Phase: N/A Priority: Normal
NCT ID: NCT00274573 Org: User:
Start: 03/31/02 End: - Due: -

Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02177370 Org: User:
Start: 02/28/90 End: - Due: -

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

Phase: N/A Priority: Normal
NCT ID: NCT00267917 Org: User:
Start: 01/17/06 End: 02/27/06 Due: 02/27/07

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667

Phase: N/A Priority: Normal
NCT ID: NCT02133482 Org: User:
Start: 07/31/14 End: 10/31/14 Due: 10/31/15

A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT04537897 Org: User:
Start: 10/06/20 End: 10/07/21 Due: 10/07/22

An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01103960 Org: User:
Start: 07/31/10 End: - Due: -

Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02260011 Org: User:
Start: 10/31/00 End: - Due: -

Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

Phase: N/A Priority: Normal
NCT ID: NCT01050062 Org: User:
Start: 01/31/10 End: 12/31/11 Due: 12/31/12

A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02597933 Org: User:
Start: 11/12/15 End: 11/28/18 Due: 11/28/19

Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02276391 Org: User:
Start: 07/31/08 End: - Due: -

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01225822 Org: User:
Start: 11/30/02 End: - Due: -

Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02640612 Org: User:
Start: 01/22/16 End: 11/01/17 Due: 11/01/18

Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01845077 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.

Phase: N/A Priority: Normal
NCT ID: NCT01343719 Org: User:
Start: 04/30/11 End: - Due: -

An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00365560 Org: User:
Start: 08/31/06 End: - Due: -

A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01707147 Org: User:
Start: 11/16/12 End: 07/11/17 Due: 07/11/18

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06070610 Org: User:
Start: 11/08/23 End: 12/14/23 Due: 12/14/24

Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172222 Org: User:
Start: 07/31/09 End: - Due: -

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01370005 Org: User:
Start: 06/30/11 End: 07/31/12 Due: 07/31/13